Marpai (MRAI) Q3 2024 earnings summary

Executive summary

• Leadership expresses strong commitment to long-term value creation, highlighting positive turnaround progress and a focus on profitability and positive cash flow, with further developments expected in Q4.

• CEO and largest shareholder made a direct investment, signaling confidence in future prospects.

• New institutional investor, IFCM MicroCap Fund, has taken a significant stake.

• Net revenues for Q3 2024 were $7.0 million, a 19.7%–20% decrease year over year, primarily due to customer turnover and market evolution.

• Net loss for Q3 2024 was $3.6 million, a 51%–51.2% improvement from Q3 2023.

Financial highlights

• Q3 2024 revenue was $7.0 million, down from $8.7 million in Q3 2023; nine-month revenue was $21.6 million.

• Q3 2024 operating loss was $3.1 million, a 56.5%–57% improvement year over year.

• Q3 2024 operating expenses were $10.1 million, down 36% year over year.

• Cash and cash equivalents at September 30, 2024, were $830 thousand, with negative working capital of $3.3 million.

• Net cash used in operating activities for the nine months ended September 30, 2024 was $10.3 million.

Outlook and guidance

• Robust sales pipeline for 2025, with multi-year contracts providing stable revenue.

• Management is seeking additional funding and may scale back operations or divest assets if capital is not secured.

• Substantial doubt exists about the company's ability to continue as a going concern over the next twelve months.

• Major project underway to reduce TPA expenses by over 25% in Q1 2025.

• Expecting organic revenue growth to return in 2025.